Medibank Private Ltd
MPL.AX- Latest Trade
- trading higher2.91AUD
- 0.01
- 0.34%
- As of Jan 29 2023. Values delayed up to 15 minutes
- Day Range
- 2.90 - 2.94
- 52-Week Range
- 2.73 - 3.79
- Previous Close
- 2.90
- Open
- 2.93
- Volume
- 7,362,261.00
- 3 Month Average Trading Volume
- 218.47
- Shares Out (Mil)
- 2,754.00
- Market Cap
- 8,014.15
- Forward P/E
- 17.00
- Dividend Yield
- 4.60
Key Statistics
2.41666667 mean rating - 12 analysts
- P/E Excl. Extra Items (TTM)
- 20.34
- Price To Sales (TTM)
- 1.13
- Price To Book (Quarterly)
- 4.12
- Price To Cash Flow (Per Share TTM)
- 15.75
- Total Debt/Total Equity (Quarterly)
- 3.95
- Long Term Debt/Equity (Quarterly)
- 2.40
- Return On Investment (TTM)
- 0.00
- Return On Equity (TTM)
- 9.29
2021 (millions USD)
About Medibank Private Ltd (MPL.AX)
Company Information
Medibank Private Ltd is an Australia-based health insurance company. The Company operates through two segments: Health Insurance and Medibank Health. The Health Insurance segment offers private health insurance products, including hospital cover provides members with health cover for hospital treatments, and ancillary cover provides members with health cover for healthcare services such as dental, optical and physiotherapy. The segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment is engaged in various activities, including contracting with government and corporate customers to provide health management services, and in-home care services, as well as providing a range of telehealth services in Australia Medibank Health segment includes diversified insurance products such as travel, life and pet. The Company underwrites and distributes private health insurance policies under the Medibank and ahm brands.
Address
720 Bourke Street, DocklandsMELBOURNE, VIC
3008
Australia
Industry
Insurance (Accident & Health)
Executive Leadership
- Michael Wilkins
- Non-Executive Independent Chairman of the Board
- David Koczkar
- Chief Executive Officer, Executive Director
- Mark Rogers
- Group Executive - Chief Financial Officer & Group Strategy
- Andrew Wilson
- Group Executive - Chief Executive Officer Amplar Health
- Kylie Bishop
- Group Executive – People, Culture & Sustainability
- Rob Deeming
- Group Executive - Customer & Brands
- John Goodall
- Group Executive - Technology and Operations
- Milosh Milisavljevic
- Group Executive - Customer Portfolios
- Mei Ramsay
- Group Executive - Legal, Governance & Compliance, Company Secretary
- Tracey Leigh Batten
- Non-Executive Independent Director
- Anna Bligh
- Non-Executive Independent Director
- Gerard Dalbosco
- Non-Executive Independent Director
- Peter Dobie Everingham
- Non-Executive Independent Director
- David Fagan
- Non-Executive Independent Director
- Kathryn Joy Fagg
- Non-Executive Independent Director
- Linda Bardo Nicholls
- Independent Non-Executive Director
Latest News
- TechnologyAustralia to consider banning paying of ransoms to cyber criminals
Australia's Home Affairs Minister Clare O'Neil on Sunday said the government would consider making illegal the paying of ransoms to cyber hackers, following recent cyber attacks affecting millions of Australians.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,927.60 | 0.12% |
| Copper | 783.30 | 1.20% |
| Brent Crude Oil | 86.66 | -- |
| CBOT Soybeans | 1,512.25 | 0.74% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,070.56 | 0.25% |
| Euro STOXX 50 | 4,178.01 | 0.10% |
| FTSE 100 | 7,765.15 | 0.05% |
| Nikkei 225 | 27,382.56 | 0.07% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes